Alpaslan Cakan Selected Research

phosphono-platelet activating factor

7/2018

Is the Risk of Postoperative Atrial Fibrillation Predictable in Patients Undergoing Surgery Due to Primary Lung Cancer?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alpaslan Cakan Research Topics

Disease

3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2017 - 11/2007
2	Neoplasms (Cancer) 02/2010 - 01/2003
1	Pneumothorax 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2018
1	Lung Neoplasms (Lung Cancer) 06/2017
1	Stab Wounds (Stab Wound) 07/2012
1	Gunshot Wounds (Gunshot Wound) 07/2012
1	Hypotension (Low Blood Pressure) 07/2012
1	Shock 07/2012
1	Wounds and Injuries (Trauma) 07/2012
1	Anemia 02/2010
1	Multifocal fibrosclerosis 01/2009
1	Pleural Neoplasms 01/2003

Drug/Important Bio-Agent (IBA)

1	phosphono-platelet activating factorIBA 07/2018
1	Carcinoembryonic AntigenIBA 06/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2009
1	Gemcitabine FDA Link 11/2007
1	Cisplatin (Platino)FDA LinkGeneric 11/2007
1	AsbestosIBA 01/2003

Therapy/Procedure

2	Pneumonectomy (Lung Volume Reduction) 01/2020 - 02/2010
1	Thoracotomy 07/2012
1	Radiotherapy 02/2010
1	Drug Therapy (Chemotherapy) 11/2007
1	Adjuvant Chemotherapy 11/2007